logo
[breadcrumb_custom]

Tag: NASDAQ:RXRX

Finance

RXRX’s Debt-to-Equity Ratio at 0.11: What It Means for Recursion Pharmaceuticals Inc’s Future

The market performance of Recursion Pharmaceuticals Inc’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $16.75 on 07/19/23, while the lowest value for the same duration was $4.54 on 05/02/23. 52-week price history of RXRX Stock A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Recursion Pharmaceuticals Inc’s current trading price is -30.67% away from its 52-week high, while its distance from the 52-week low is 155.70%. The stock’s price range during this period has spanned from $4.54 to $16.75. In

HCCC Stock
News

Recursion Pharmaceuticals Inc Inc. (RXRX) Price Performance: The Role of Supply and Demand

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The index has shown a price gain of 5.17% this year. Over the last six months, there has been a weaker performance of 28.66%. The price of RXRX fallen by 4.75% during the last 30 days period. For the last 5-days stocks have slided -15.69%. Recursion Pharmaceuticals Inc’s stock has had a calm market performance. The 1-year high for the company’s stock was $16.75 on 07/19/23, and the lowest price during the same period

SLGG
News

Company’s Banking Stock: Dissecting a 79.56% Quarterly Revenue Decline Amid Growth

Recursion Pharmaceuticals Inc’s stock market performance has been consistent. The 1-year high for the company’s stock was recorded at $16.75 on 07/19/23, with the lowest value being $4.54 on 05/02/23. 52-week price history of RXRX Stock Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Recursion Pharmaceuticals Inc’s current trading price is -26.55% away from its 52-week high, while its distance from the 52-week low is 170.93%. The stock’s price range for this period has remained between $4.54 and $16.75. The Healthcare sector

VIPS stock
Stock

RXRX’s Stock Market Adventure: 35.60% YTD Growth Amidst Volatility

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The index has shown a price gain of 35.60% this year. Over the last six months, there has been a weaker performance of 42.54%. The price of RXRX fallen by 29.05% during the last 30 days period. For the last 5-days stocks have improved 7.56%. Recursion Pharmaceuticals Inc had a pretty favorable run when it comes to the market performance. Over the past year, the company’s stock reached a high of $16.75 on 07/19/23,

Finance

A Tale of Resilience: Recursion Pharmaceuticals Inc Amid Stock Market Turbulence

Recursion Pharmaceuticals Inc’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $16.75 on 07/19/23 and a low of $4.54 for the same time frame on 05/02/23. 52-week price history of RXRX Stock A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Recursion Pharmaceuticals Inc’s current trading price is -21.47% away from its 52-week high, while its distance from the 52-week low is 189.65%. The stock’s price range during this period has spanned from $4.54 to $16.75. In the Healthcare sector, the Recursion Pharmaceuticals Inc’s

News

Recursion Pharmaceuticals Inc Inc. (RXRX) Price Performance: A Fundamental Analysis Perspective

Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. This year’s metric has recorded a Price increase of 1.51%. However, over the past six months, we’ve seen a weaker performance of 7.39%. The price of RXRX leaped by -10.32% over the last 30 days. And in the last five days, it has surged by 5.58%. Recursion Pharmaceuticals Inc had a pretty favorable run when it comes to the market performance. Over the past year, the company’s stock reached a high of $16.75

SLGG
Stock

RXRX’s Market Whiplash: -7.40% YTD Decline, -27.60% Plunge in 30 Days

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Until today this year the stock’s price performance recorded a decrease of -7.40%. However, over the last six months, the performance has been stronger by -20.95%. The price of RXRX decreased -27.60% over the last 30 days. And in the last five days, it has fallen by -2.98%. Recursion Pharmaceuticals Inc saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $16.75 on 07/19/23, while the lowest

Stock

Recursion Pharmaceuticals Inc Inc. (RXRX) Price Performance and Its Relation to the Tech Industry

Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Year to date metric has recorded a loss of -0.20%.However, over the last six months, we can see a stronger performance of -30.31%. Over the last 30 days, the price of RXRX has leaped by -7.26%. And in the last five days, it has fallen by -7.52%. Recursion Pharmaceuticals Inc experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $16.75 on 07/19/23, while the lowest

ZM Stock
Finance

Recursion Pharmaceuticals Inc (RXRX) Stock: A Comprehensive 52-Week Review

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Recursion Pharmaceuticals Inc’s current trading price is -37.12% away from its 52-week high, while its distance from the 52-week low is 131.94%. The stock’s price range over this period has fluctuated between $4.54 and $16.75. The company, operating within the financial sector, had a trading volume of approximately 1.54 million for the day, which was noticeably lower than the average daily share volume of 5.36 million over the last 3 months. In terms of market performance, Recursion